Table II.
Sample type | Sample/isolate details | Total reads | Per cent of reads mapped | Per cent of genome recovered | Position of nucleotide in genome[17] | |
---|---|---|---|---|---|---|
8782 | 28144 | |||||
Isolate | NIV-2020-763 | 10,054,258 | 94.8 | 100 | C | T |
NIV-2020-770 | 4,384,130 | 99.0 | 100 | C | T | |
NIV-2020-772 | 3,482,648 | 98.4 | 99.9 | C | T | |
NIV-2020-773 | 5,952,758 | 94.2 | 99.9 | C | T | |
NIV-2020-777 | 3,949,748 | 98.7 | 100 | C | T | |
NIV-2020-781 | 2,226,464 | 91.6 | 99.9 | C | T | |
NIV-2020-C32 | 4,159,878 | 99.0 | 100 | C | T | |
Clinical sample | nCoV-763 | 8,721,610 | 84.9 | 99.9 | T | T |
nCoV-770 | 5,197,614 | 93.1 | 99.9 | T | T | |
nCoV-772 | 4,222,912 | 81.7 | 99.8 | C | T | |
nCoV-773 | 9,951,190 | 19.98 | 99.8 | C | T | |
nCoV-777 | 8,808,756 | 26.93 | 99.8 | C | T | |
nCoV-781 | 15,688,460 | 35.5 | 99.9 | C | T | |
nCoV-C32 | 2,772,158 | 88.5 | 100 | C | T |